{
    "2021-08-30": [
        [
            {
                "time": "2023-10-20",
                "original_text": "Novartis presents important overall survival and quality-of-life results across solid tumor portfolio, among other key data at ESMO",
                "features": {
                    "keywords": [
                        "Novartis",
                        "important",
                        "overall survival",
                        "quality-of-life",
                        "solid tumor",
                        "ESMO"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}